JVM Co

JVM Co FCF Yield

The Free Cash Flow Yield of JVM Co (054950.KQ) as of Nov 4, 2026 is 8.47 %. In the previous year, Free Cash Flow Yield was 7.39 % — a change of 14.62% (higher).

FCF Yield

8.47 %

YoY

14.62%

Last updated:

Free Cash Flow Yield of JVM Co is 2025 8.47 % . Free Cash Flow Yield of JVM Co was 2024 7.39 % . It decreases by 14.62% higher compared to the previous year.

The JVM Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
5.13 KRW
Jan 1, 2019
4.59 KRW
Jan 1, 2020
4.21 KRW
Jan 1, 2021
6.96 KRW
Jan 1, 2022
3.34 KRW
Jan 1, 2023
8.84 KRW
Jan 1, 2024
7.39 KRW
Jan 1, 2025
8.47 KRW
The JVM Co FCF Yield history
YEARFCF YieldYoY
8.47 %+14.62%
7.39 %-16.45%
8.84 %+164.84%
3.34 %-52.02%
6.96 %+65.44%
4.21 %-8.25%
4.59 %-10.67%
5.13 %+31.87%
3.89 %+77.93%
2.19 %+5.12%
2.08 %-61.40%
5.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Free Cash Flow Yield of JVM Co is 8.47 % in 2025.

Free Cash Flow Yield of JVM Co changed from 7.39 % to 8.47 %, representing a 14.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield JVM Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — JVM Co

All Key Metrics — JVM Co